Skip to main content
NIH funding notice RFA-DA-25-052

Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional)

Closed on March 14, 2024.

Posted
October 25, 2023
Close date
March 14, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $610,743 in first-year total cost, median $305,372.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 PXN-S (O1)]2

Most frequent institutions

  1. ADDINEX TECHNOLOGIES, INC.1
  2. CARINA MEDICAL, LLC1
Competing awards under RFA-DA-25-052 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorder1R43DA062234-01ROSLYAKOV, STANISLAVADDINEX TECHNOLOGIES, INC., NY$306,528ZDA1
2025Development of Validation of a Novel Software Platform for Decentralized Clinical Trial in Substance Use Disorder Incorporating Large Language Models1R43DA062307-01FENG, XUECARINA MEDICAL, LLC, VA$304,215ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-25-052: Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional) | ScienceDex | ConductScience